ADMA ADMA Biologics Inc gains 20% Nov 29, 2017

Posted By: Rajesh Srivastava - Wednesday, November 29, 2017

Share

& Comment

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a plasma collection center. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey. http://www.priceseries.com/trade/ADMA-ADMA-Biologics-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017111320171129.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.